SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001711279-23-000039
Filing Date
2023-05-22
Accepted
2023-05-22 07:32:55
Documents
15
Period of Report
2023-05-22
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K krys-20230522.htm   iXBRL 8-K 49752
2 EX-10.1 exhibit101securities_purch.htm EX-10.1 222153
3 EX-10.2 exhibit102registrationrigh.htm EX-10.2 203327
4 EX-99.1 exhibit991pressrelease.htm EX-99.1 9953
  Complete submission text file 0001711279-23-000039.txt   687170

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT krys-20230522.xsd EX-101.SCH 1914
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT krys-20230522_lab.xml EX-101.LAB 22164
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT krys-20230522_pre.xml EX-101.PRE 11598
9 EXTRACTED XBRL INSTANCE DOCUMENT krys-20230522_htm.xml XML 9791
Mailing Address 2100 WHARTON STREET SUITE 701 PITTSBURGH PA 15203
Business Address 2100 WHARTON STREET SUITE 701 PITTSBURGH PA 15203 (412) 586-5830
Krystal Biotech, Inc. (Filer) CIK: 0001711279 (see all company filings)

IRS No.: 821080209 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38210 | Film No.: 23942442
SIC: 2836 Biological Products, (No Diagnostic Substances)